Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial
- 1 December 1994
- journal article
- clinical trial
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 87 (4) , 355-365
- https://doi.org/10.1007/bf01203344
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The effect of an aldose reductase inhibitor (Sorbinil®) on diabetic neuropathy and neural function of the retina: a double-blind studyActa Neurologica Scandinavica, 2009
- The role of aldose reductase in the development of diabetic complicationsMedicinal Research Reviews, 1988
- Diabetic retinopathy: A clinical overviewDiabetes/Metabolism Research and Reviews, 1988
- The involvement of aldose reductase in diabetic complicationsDiabetes/Metabolism Research and Reviews, 1988
- Inhibition of aldose reductase from human retinaCurrent Eye Research, 1987
- Human safety profile of tolrestat: An aldose reductase inhibitorDrug Development Research, 1987
- Experimental diabetes mellitus impairs the function of the retinal pigmented epitheliumMetabolism, 1986
- Hyperglycemia as a cause of diabetic retinopathyMetabolism, 1986
- Aldose Reductase Inhibitors in Clinical Practice Preliminary Studies on Diabetic Neuropathy and RetinopathyDrugs, 1986
- An Approximate Analysis of Variance Test for Non-Normality Suitable for Machine CalculationTechnometrics, 1975